Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 15, Number 29, 2009

Articles

Favourites:
ADD
Favourites:
ADD

Developing Novel Therapeutic Approaches to Frailty
pp. 3384-3395(12)
Author: Morley, John E.

Favourites:
ADD

Role of Chemokines and Their Receptors in Cancer
pp. 3396-3416(21)
Authors: Kruizinga, Roeliene C.; Bestebroer, Jovanka; Berghuis, Paul; de Haas, Carla J.C.; Links, Thera P.; de Vries, Elisabeth G.E.; Walenkamp, Annemiek M.E.

Favourites:
ADD

Vascular Damage in Impaired Glucose Tolerance: An Unappreciated Phenomenon?
pp. 3417-3432(16)
Authors: Jessani, Shahirose; Millane, Teri; Lip, Gregory Y.H.

Favourites:
ADD

Mast Cells: Target and Source of Neuropeptides
pp. 3433-3445(13)
Authors: Tore, F.; Tuncel, N.

Favourites:
ADD

Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome
pp. 3446-3462(17)
Authors: Florentin, M.; Elisaf, M. S.; Mikhailidis, D. P.; Liberopoulos, E. N.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content